Ohio to receive $6.3 million in Johnson & Johnson settlement
Ohio Attorney General Dave Yost announced a multistate settlement Thursday that requires Johnson & Johnson to pay nearly $117 million for their deceptive marketing.
In the settlement, Ohio will receive $6.3 million.
The settlement comes after an investigation into the company's marketing of transvaginal surgical mesh devices.
According to the release, a multistate investigation found that the company violated state consumer protection laws by misrepresenting the safety of the devices and failed to disclose the risks of the product sufficiently.
"Patients can't make the best decision for their health unless they and their health care providers know all the pros and cons of a product," Yost said. "These companies didn't paint a clear picture of the device's medical risks, preventing patients from making well-informed decisions."
The release states that transvaginal mesh is a synthetic material that is surgically implanted through the vagina and supports pelvic organs. The mesh is usually implanted into women suffering from stress urinary incontinence or pelvic organ prolapse.
The investigation found that the company did not adequately disclose the adverse effects that were associated with the product. Those effects include chronic pain and inflammation, mesh erosion, painful sexual relations, and vaginal scarring.
According to the release, Johnson & Johnson has agreed to pay $116.9 million to the 41 states and DC.
21 News reached out to the Ohio Attorney General's Office to see if any money is coming to the Valley but have not received a call back.